Evidence map›Paper›PMID 30626694›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2019

Cutting Edge: HDAC3 Protects Double-Positive Thymocytes from P2X7 Receptor-Induced Cell Death.

Rachael L Philips, Shaylene A McCue, Matthew J Rajcula, Virginia S Shapiro

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Role of Histone Deacetylases in T-Cell Development and Function.International journal of molecular sciences · 2022
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Rachael L PhilipsDepartment of Immunology, Mayo Clinic, Rochester, MN 59905.
Shaylene A McCueDepartment of Immunology, Mayo Clinic, Rochester, MN 59905.
Matthew J RajculaDepartment of Immunology, Mayo Clinic, Rochester, MN 59905.
Virginia S ShapiroDepartment of Immunology, Mayo Clinic, Rochester, MN 59905 Shapiro.Virginia1@mayo.edu.ORCID 0000-0001-9978-341X
Mayo Clinic · US

Funding

PHD TRAINING PROGRAM IN BASIC IMMUNOLOGYT32AI007425 · NIAID · MAYO CLINIC ROCHESTER · PI SHAPIRO, VIRGINIA SMITH · 1995 to 2020
$3.6M
Regulation of T cell development by HDAC3R56AI122746 · NIAID · MAYO CLINIC ROCHESTER · PI SHAPIRO, VIRGINIA SMITH · 2017 to 2017
$603k
NIAID NIH HHS R56 AI122746NIAID NIH HHS T32 AI007425
6 · The paper itself

Abstract

Intricate life-versus-death decisions are programmed during T cell development, and the regulatory mechanisms that coordinate their activation and repression are still under investigation. In this study, HDAC3-deficient double-positive (DP) thymocytes exhibit a severe decrease in numbers. The thymic cortex is rich in ATP, which is released by macrophages that clear apoptotic DP thymocytes that fail to undergo positive selection. We demonstrate that HDAC3 is required to repress expression of the purinergic receptor P2X7 to prevent DP cell death. HDAC3-deficient DP thymocytes upregulate the P2X7 receptor, increasing sensitivity to ATP-induced cell death. P2rx7/HDAC3-double knockout mice show a partial rescue in DP cell number. HDAC3 directly binds to the

Indexed as

Cell DeathAnimalsHistone Deacetylase 3Histone DeacetylasesMiceMice, KnockoutNuclear Receptor Subfamily 1, Group F, Member 3Receptors, Purinergic P2X7ThymocytesHistone Deacetylase 3Histone DeacetylasesNuclear Receptor Subfamily 1, Group F, Member 3Receptors, Purinergic P2X7Rorc protein, mouse

Identifiers

PMID30626694
PMCPMC6363889
OpenAlexW2911033242

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.